Alzheimer; News from the web:

Truly great news today, the new drug Aducanumab has been approved by the FDA for use in early Alzheimer’s cases.

The drug was developed for patients with mild cognitive impairment, not severe dementia, and intended to slow progression of Alzheimer’s disease — not just ease symptoms.

Read all about it HERE